诺和诺德盘前涨2.22% 与Deep Apple达成一项研究合作与全球独家许可协议

金吾资讯
12 Jun

金吾财讯 | 诺和诺德(NVO)盘前股价拉升,暂报80.48美元,涨2.22%。消息面上,Deep Apple Therapeutics, Inc. 周三宣布,已与诺和诺德公司(Novo Nordisk A/S,NYSE:NVO)达成一项研究合作与全球独家许可协议,双方将共同发现、开发并商业化用于治疗心脏代谢类疾病(包括肥胖症)的口服小分子疗法,靶点为一种新型非促胰素类的GPCR(G蛋白偶联受体)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10